Patents by Inventor Frank R. Brennan

Frank R. Brennan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified plant viruses and methods of use thereof
    Patent number: 7666624
    Abstract: The present invention relates to modulating the nature and/or level of an immune response to a molecule. In particular, the invention relates to effecting an increase in the TH1 immune response to molecules such as, but not limited to, antigens or immunogens. The invention also relates to reducing a TH2 immune response to molecules. More particularly, the invention relates to altering the level of TH1- and TH2-associated immunoglobulins, the level of proliferation of TH1- and TH2-associated cytokines, and the level of proliferation of TH1 and TH2 cells.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: February 23, 2010
    Assignee: Dow Global Technologies Inc.
    Inventor: Frank R. Brennan
  • Modified plant viruses and methods of use thereof
    Publication number: 20080124358
    Abstract: The present invention relates to modulating the nature and/or level of an immune response to a molecule. In particular, the invention relates to effecting an increase in the TH1 immune response to molecules such as, but not limited to, antigens or immunogens. The invention also relates to reducing a TH2 immune response to molecules. More particularly, the invention relates to altering the level of TH1- and TH2-associated immunoglobulins, the level of proliferation of TH1- and TH2-associated cytokines, and the level of proliferation of TH1 and TH2 cells.
    Type: Application
    Filed: July 20, 2007
    Publication date: May 29, 2008
    Inventor: Frank R. Brennan
  • Modified plant viruses and methods of use thereof
    Patent number: 7267963
    Abstract: The present invention relates to modulating the nature and/or level of an immune response to a molecule. In particular, the invention relates to effecting an increase in the TH1 immune response to molecules such as, but not limited to, antigens or immunogens. The invention also relates to reducing a TH2 immune response to molecules. More particularly, the invention relates to altering the level of TH1- and TH2-associated immunoglobulins, the level of proliferation of TH1- and TH2-associated cytokines, and the level of proliferation of TH1 and TH2 cells.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: September 11, 2007
    Inventor: Frank R. Brennan